Jose Fernando Moura, Member of the Oncology Committee at Cremepe, shared a post on X:
“Not everything that looks like progress… is progress.
A new strategy delayed cancer progression. Still not approved by the FDA.
Because changing a number isn’t the same as improving a life. Treating better… or just earlier?”
Other articles featuring Jose Fernando Moura on OncoDaily.
